Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Autoimmune Disorders

  Free Subscription


11.02.2019

2 Acta Neurol Scand
1 Ann Neurol
1 BMC Neurol
3 Brain
1 Diabetes
6 Intern Med
1 J Autoimmun
3 J Neurol
1 J Pediatr
3 J Rheumatol
1 Kidney Int
3 Lancet
1 Lancet Diabetes Endocrinol
2 Lancet Neurol
4 Mult Scler
1 Nat Rev Neurol
1 PLoS Med
4 PLoS One
6 Proc Natl Acad Sci U S A
1 Thyroid


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neurol Scand

  1. DE BERNARDO M, Vitiello L, Rosa N
    Optic nerve ultrasound measurement in multiple sclerosis.
    Acta Neurol Scand. 2019 Feb 5. doi: 10.1111/ane.13072.
    PubMed     Text format     Abstract available

  2. CANDELIERE MERLICCO A, Gabaldon Torres L, Villaverde Gonzalez R, Fernandez Romero I, et al
    Response to: Comment on "Transorbital ultrasonography for measuring optic nerve atrophy in multiple sclerosis".
    Acta Neurol Scand. 2019 Feb 5. doi: 10.1111/ane.13076.
    PubMed     Text format     Abstract available


    Ann Neurol

  3. FADDA G, Brown RA, Magliozzi R, Aubert-Broche B, et al
    A surface-in gradient of thalamic damage evolves in pediatric multiple sclerosis.
    Ann Neurol. 2019 Feb 4. doi: 10.1002/ana.25429.
    PubMed     Text format     Abstract available


    BMC Neurol

  4. LI X, Yuan J, Liu L, Hu W, et al
    Antibody-LGI 1 autoimmune encephalitis manifesting as rapidly progressive dementia and hyponatremia: a case report and literature review.
    BMC Neurol. 2019;19:19.
    PubMed     Text format     Abstract available


    Brain

  5. ALLENBACH Y, Bolko L, Toquet S, Landon-Cardinal O, et al
    Reply: Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis.
    Brain. 2019 Feb 1. pii: 5305679. doi: 10.1093.
    PubMed     Text format    

  6. EDEN D, Gros C, Badji A, Dupont SM, et al
    Spatial distribution of multiple sclerosis lesions in the cervical spinal cord.
    Brain. 2019 Jan 30. pii: 5304670. doi: 10.1093.
    PubMed     Text format     Abstract available

  7. PAPADOPOULOU C, Hong Y, Omoyinmi E, Brogan PA, et al
    Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis.
    Brain. 2019 Feb 1. pii: 5305681. doi: 10.1093.
    PubMed     Text format    


    Diabetes

  8. TORELLA D, Iaconetti C, Tarallo R, Marino F, et al
    MicroRNA Regulation of the Hyper-Proliferative Phenotype of Vascular Smooth Muscle Cells in Diabetes Mellitus.
    Diabetes. 2018 Sep 26. pii: db17-1434. doi: 10.2337/db17-1434.
    PubMed     Text format     Abstract available


    Intern Med

  9. ONDA A, Miyagawa S, Takahashi N, Gochi M, et al
    Pembrolizumab-induced Ocular Myasthenia Gravis with Anti-titin Antibody and Necrotizing Myopathy.
    Intern Med. 2019 Feb 1. doi: 10.2169/internalmedicine.1956.
    PubMed     Text format     Abstract available

  10. HSIAO CC, Lee CC, Chen KH
    Successful Treatment of Tumoral Calcinosis by Lanthanum Carbonate.
    Intern Med. 2018;57:3589-3591.
    PubMed     Text format     Abstract available

  11. AZUMA S, Kurita A, Yazumi S
    Autoimmune Pancreatitis Exhibiting Pancreatic Duct Wall Thickening.
    Intern Med. 2019 Feb 1. doi: 10.2169/internalmedicine.2243.
    PubMed     Text format    

  12. OKAMOTO A, Watanabe T, Kamata K, Minaga K, et al
    Recent Updates on the Relationship between Cancer and Autoimmune Pancreatitis.
    Intern Med. 2019 Feb 1. doi: 10.2169/internalmedicine.2210.
    PubMed     Text format     Abstract available

  13. KIMURA M, Aizawa A, Miyauchi S, Hasuike S, et al
    Peliosis Hepatis Due to Corticosteroid in Systemic Lupus Erythematosus.
    Intern Med. 2019 Feb 1. doi: 10.2169/internalmedicine.2167.
    PubMed     Text format    

  14. SO C, Imai R, Tomishima Y, Nishimura N, et al
    Bilateral Pleuritis as the Initial Symptom of Systemic Lupus Erythematosus: A Case Series and Literature Review.
    Intern Med. 2019 Feb 1. doi: 10.2169/internalmedicine.1886.
    PubMed     Text format     Abstract available


    J Autoimmun

  15. KREBS CF, Panzer U
    Plasticity and heterogeneity of Th17 in immune-mediated kidney diseases.
    J Autoimmun. 2018;87:61-68.
    PubMed     Text format     Abstract available


    J Neurol

  16. KIM SW, Choi YC, Kim SM, Shim HS, et al
    Effect of thymectomy in elderly patients with non-thymomatous generalized myasthenia gravis.
    J Neurol. 2019 Feb 6. pii: 10.1007/s00415-019-09222.
    PubMed     Text format     Abstract available

  17. LEBRUN-FRENAY C, Moulignier A, Pierrot-Deseilligny C, Benrabah R, et al
    Five-year outcome in the copaxone observatory: a nationwide cohort of patients with multiple sclerosis starting treatment with glatiramer acetate in France.
    J Neurol. 2019 Feb 7. pii: 10.1007/s00415-019-09211.
    PubMed     Text format     Abstract available

  18. GAMRAOUI S, Mathey G, Debouverie M, Malaplate C, et al
    High performance of cerebrospinal fluid immunoglobulin G analysis for diagnosis of multiple sclerosis.
    J Neurol. 2019 Feb 1. pii: 10.1007/s00415-019-09212.
    PubMed     Text format     Abstract available


    J Pediatr

  19. WEHRMAN A, Waisbourd-Zinman O, Shah A, Hilmara D, et al
    Steroid Free Treatment of Autoimmune Hepatitis in Selected Children.
    J Pediatr. 2019 Feb 2. pii: S0022-3476(19)30022.
    PubMed     Text format     Abstract available


    J Rheumatol

  20. LIU LH, Fevrier HB, Goldfien R, Hemmerling A, et al
    Understanding Non-Adherence with Hydroxychloroquine Therapy in Systemic Lupus Erythematosus.
    J Rheumatol. 2019 Feb 1. pii: jrheum.180946. doi: 10.3899/jrheum.180946.
    PubMed     Text format     Abstract available

  21. UROWITZ MB, Su J, Gladman DD
    Atherosclerotic Vascular Events in Systemic Lupus Erythematosus - an Evolving Story.
    J Rheumatol. 2019 Feb 1. pii: jrheum.180986. doi: 10.3899/jrheum.180986.
    PubMed     Text format     Abstract available

  22. BARBACKI A, Petri M, Avina-Zubieta A, Alarcon GS, et al
    Fatigue Measurements in Systemic Lupus Erythematosus.
    J Rheumatol. 2019 Feb 1. pii: jrheum.180831. doi: 10.3899/jrheum.180831.
    PubMed     Text format     Abstract available


    Kidney Int

  23. KITAGAWA A, Tsuboi N, Yokoe Y, Katsuno T, et al
    Urinary levels of the leukocyte surface molecule CD11b associate with glomerular inflammation in lupus nephritis.
    Kidney Int. 2019 Jan 26. pii: S0085-2538(18)30826.
    PubMed     Text format     Abstract available


    Lancet

  24. THE LANCET
    Type 2 diabetes: the urgent need to protect young people.
    Lancet. 2018;392:2325.
    PubMed     Text format    

  25. YUAN K, Huang G, Sang X, Xu A, et al
    Baricitinib for systemic lupus erythematosus.
    Lancet. 2019;393:402.
    PubMed     Text format    

  26. WALLACE DJ, Furie RA, Tanaka Y, de Bono S, et al
    Baricitinib for systemic lupus erythematosus - Authors' reply.
    Lancet. 2019;393:402-403.
    PubMed     Text format    


    Lancet Diabetes Endocrinol

  27. FORBES S, Senior PA, Shapiro AMJ
    Islet transplantation in type 1 diabetes: moving forward.
    Lancet Diabetes Endocrinol. 2018 May 15. pii: S2213-8587(18)30107.
    PubMed     Text format    


    Lancet Neurol

  28. DE MEEL RHP, Verschuuren JJGM, Tannemaat MR
    Distinct representation of muscle weakness in QMG and MG-ADL.
    Lancet Neurol. 2018;17:204-205.
    PubMed     Text format    

  29. HOWARD JF JR, O'Brien F, Wang JJ
    Distinct representation of muscle weakness in QMG and MG-ADL - Authors' reply.
    Lancet Neurol. 2018;17:205-206.
    PubMed     Text format    


    Mult Scler

  30. PLANCHE V, Su JH, Mournet S, Saranathan M, et al
    White-matter-nulled MPRAGE at 7T reveals thalamic lesions and atrophy of specific thalamic nuclei in multiple sclerosis.
    Mult Scler. 2019 Feb 7:1352458519828297. doi: 10.1177/1352458519828297.
    PubMed     Text format     Abstract available

  31. RAIMO S, Spitaleri D, Trojano L, Santangelo G, et al
    Apathy as a herald of cognitive changes in multiple sclerosis: A 2-year follow-up study.
    Mult Scler. 2019 Feb 7:1352458519828296. doi: 10.1177/1352458519828296.
    PubMed     Text format     Abstract available

  32. NICOLETTI CG, Monteleone F, Marfia GA, Usiello A, et al
    Oral D-Aspartate enhances synaptic plasticity reserve in progressive multiple sclerosis.
    Mult Scler. 2019 Feb 7:1352458519828294. doi: 10.1177/1352458519828294.
    PubMed     Text format     Abstract available

  33. LEFEUVRE JA, Guy JR, Luciano NJ, Ha SK, et al
    The spectrum of spinal cord lesions in a primate model of multiple sclerosis.
    Mult Scler. 2019 Feb 7:1352458518822408. doi: 10.1177/1352458518822408.
    PubMed     Text format     Abstract available


    Nat Rev Neurol

  34. KELSEY R
    Prolonging the integrated stress response could be beneficial in multiple sclerosis.
    Nat Rev Neurol. 2019 Feb 4. pii: 10.1038/s41582-019-0142.
    PubMed     Text format    


    PLoS Med

  35. BONIFACIO E, Beyerlein A, Hippich M, Winkler C, et al
    Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: A prospective study in children.
    PLoS Med. 2018;15:e1002548.
    PubMed     Text format     Abstract available


    PLoS One

  36. LABAN S, Suwandi JS, van Unen V, Pool J, et al
    Heterogeneity of circulating CD8 T-cells specific to islet, neo-antigen and virus in patients with type 1 diabetes mellitus.
    PLoS One. 2018;13:e0200818.
    PubMed     Text format     Abstract available

  37. NACKA-ALEKSIC M, Stojanovic M, Pilipovic I, Stojic-Vukanic Z, et al
    Strain differences in thymic atrophy in rats immunized for EAE correlate with the clinical outcome of immunization.
    PLoS One. 2018;13:e0201848.
    PubMed     Text format     Abstract available

  38. MOHN J, Igland J, Zoffmann V, Peyrot M, et al
    Factors explaining variation in self-esteem among persons with type 1 diabetes and elevated HbA1c.
    PLoS One. 2018;13:e0201006.
    PubMed     Text format     Abstract available

  39. MARTIN NA, Nawrocki A, Molnar V, Elkjaer ML, et al
    Orthologous proteins of experimental de- and remyelination are differentially regulated in the CSF proteome of multiple sclerosis subtypes.
    PLoS One. 2018;13:e0202530.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  40. LEIBOVITCH EC, Jacobson S
    Reply to Zahednasab et al.: HHV-6 and marmoset EAE.
    Proc Natl Acad Sci U S A. 2018;115:E12127.
    PubMed     Text format    

  41. GRAHAM KL, Werner BJ, Moyer KM, Patton AK, et al
    DGAT1 inhibits retinol-dependent regulatory T cell formation and mediates autoimmune encephalomyelitis.
    Proc Natl Acad Sci U S A. 2019 Feb 4. pii: 1817669116.
    PubMed     Text format     Abstract available

  42. MCALPINE W, Sun L, Wang KW, Liu A, et al
    Excessive endosomal TLR signaling causes inflammatory disease in mice with defective SMCR8-WDR41-C9ORF72 complex function.
    Proc Natl Acad Sci U S A. 2018;115:E11523-E11531.
    PubMed     Text format     Abstract available

  43. TOKUYAMA M, Kong Y, Song E, Jayewickreme T, et al
    ERVmap analysis reveals genome-wide transcription of human endogenous retroviruses.
    Proc Natl Acad Sci U S A. 2018;115:12565-12572.
    PubMed     Text format     Abstract available

  44. DUNCAN ID, Radcliff AB, Heidari M, Kidd G, et al
    The adult oligodendrocyte can participate in remyelination.
    Proc Natl Acad Sci U S A. 2018;115:E11807-E11816.
    PubMed     Text format     Abstract available

  45. ZAHEDNASAB H, Keyvani H, Karampour S, Harirchian MH, et al
    Role of HHV-6 subtypes in accelerating EAE progression.
    Proc Natl Acad Sci U S A. 2018;115:E12126.
    PubMed     Text format    


    Thyroid

  46. SCHRIJVER B, Kooiman MA, Kasteleijn E, van Holten-Neelen C, et al
    BASIC FIBROBLAST GROWTH FACTOR INDUCES ADIPOGENESIS IN ORBITAL FIBROBLASTS; IMPLICATION FOR THE PATHOGENESIS OF GRAVES' ORBITOPATHY.
    Thyroid. 2019 Feb 6. doi: 10.1089/thy.2018.0544.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: